The South African Oppenheimer family is set to pocket $990,552 in dividends from its indirect stake in the leading UK-based consumer healthcare company, Integrated Diagnostics Holdings Plc (IDH).
IDH is a leading healthcare provider with an operational footprint in the Middle East and Africa through subsidiaries in Egypt, Jordan, Sudan and Nigeria.
It was founded in 2012 and is headquartered in Saint Helier, UK.
In 2020, the company posted a 21-percent increase in profits on the back of a 19-percent surge in revenues.
Its robust performance that year was supported by IDH’s ability to adapt its service offerings to the industry’s changing dynamics, which were spiked by a shift in consumer preferences.
These changing dynamics led the company to ramp up its housecall services in Jordan and Egypt, thus enabling the healthcare provider to capture the rising demand for COVID-19-related tests, which contributed 24 percent of its consolidated revenue for the year.
Considering its impressive financial results for 2020, the company’s board of directors recommended a final dividend of $0.049 per share.
This translates to a total dividend of $29.1 million for shareholders in respect to profits in 2020.
The aggregate dividend of $29.1 million is four percent higher than its final dividend of $28 million for the previous financial year.
The Oppenheimer family is a top shareholder in the leading healthcare provider.
The family’s 3.37-percent stake in the company, which amounts to 20,215,360 ordinary shares, will set them on course to pocket a total dividend of $990,552 on July 29.
As of press time, 2:30 PM (UTC), July 14, the family’s equity stake in IDH is valued at $24.56 million.
